BioCentury | May 14, 2020
Management Tracks

Former GSK exec Slaoui to lead Trump’s ‘Warp Speed’ vaccine initiative

...While at GSK, Slaoui led the development of several vaccines, including Rotarix for infantile gastroenteritis, Synflorix...
BioCentury | Nov 30, 2017
Clinical News

WHO gives prequalification to GSK's four-dose pneumococcal vaccine

...said the World Health Organization (WHO) gave prequalification to a 4-dose vial of pneumococcal vaccine Synflorix...
...the world's poorest countries. Local registration for the 4-dose vial in GAVI-supported countries is ongoing. Synflorix...
...derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix) Business: Infectious Allison Johnson Synflorix GlaxoSmithKline...
BioCentury | Mar 18, 2016
Top Story

Retiring Witty reveals new GSK initiatives

...use of Synflorix vaccine against pneumococcal disease, and said GSK is cutting the price of Synflorix...
BioCentury | Apr 6, 2015
Clinical News

Synflorix regulatory update

...Japan approved Synflorix to prevent invasive infectious diseases and pneumonia caused by pneumococcus in infants. Synflorix...
...Tokyo, Japan), a 50/50 JV between GSK and Daiichi Sankyo Co. Ltd. (Tokyo:4568, Tokyo, Japan). Synflorix...
...protein Haemophilus influenzae-derived protein D. GlaxoSmithKline pl c (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...
BioCentury | Jun 9, 2014
Company News

GlaxoSmithKline, Global Alliance for Vaccine Immunization (GAVI) infectious news

...developing countries for five years after each country graduates from GAVI support. GSK provides its Synflorix...
BioCentury | May 12, 2014
Clinical News

Synflorix regulatory update

...Tokyo, Japan) submitted an application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Synflorix...
...against invasive disease and acute otitis media caused by S. pneumoniae in the age group. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...
BioCentury | Dec 16, 2013
Clinical News

Synflorix regulatory update

...The European Commission approved an expanded label for Synflorix vaccine from GlaxoSmithKline to include vaccination against...
...against invasive disease and acute otitis media caused by S. pneumoniae in the age group. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...
BioCentury | Nov 4, 2013
Clinical News

Synflorix regulatory update

...EMA's CHMP issued a positive opinion recommending expanding the label of Synflorix vaccine from GlaxoSmithKline to...
...in the age group. GSK expects a final decision from the European Commission this quarter. Synflorix...
...carrier protein Haemophilus influenzae-derived protein D. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...
BioCentury | Sep 12, 2013
Distillery Techniques

Technology: Drug platforms

...steps include developing a multivalent version of the vaccine targeting other bacterial antigens. GlaxoSmithKline plc's Synflorix...
BioCentury | Dec 17, 2012
Clinical News

Synflorix: Phase III data

...2+1 dosing schedule of Synflorix vs. 12 cases in children receiving hepatitis vaccines as controls. Synflorix...
...GSK said it plans to submit the data to regulatory authorities for inclusion in the Synflorix...
...Data were published in The Lancet. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Synflorix (formerly Streptorix...
Items per page:
1 - 10 of 30